DAFTAR PUSTAKA
1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ et al.
National, regional, and global trends in fasting plasma glucose and diabetes
prevalence since 1980: systematic analysis of health examination surveys
and epidemiological studies with 370 country-years and 2.7 million
participants.Lancet2011;378(9785):31–40.
2. French LA, Boen JR, Martinez AM et al. Population Based Study Impaired
Glucose Tolerance and Type 2 diabetes in Wadena, minesota. Diabetes;
1990.
3. Wild,S et al. Global Prevalence of diabetes. Estimates for Year 2000 and
Projections for 2030. Diabetes Care 2004 ;27 (5): 1047-1053.
4. Soegondo S, purnamasari D Waspadji S, saksono D. Prevalensi of diabetes
mellitus in Jakarta. The Jakarta primary non communicable disease risk
factors surveillance .2006.
5. Anonim. Buku Profil Kesehatan Provinsi JawaTengah Tahun 2012. Dinas
Kesehatan Jawa Tengah : Semarang. 2012.
6. Anonim. Data Kementrian Kesehatan RI Tahun 2010. Jakarta.
7. Ram vinod mahato, prajwal Gyawali, Pramod Psd. Assosiated between
glycemic control and serum lipid profile in type 2 diabetes patient: HbA1c
8. Karel Pandelaki. Diabetic dyslipidemia management. The first east
Indonesia Endo-metabolic update. PERKENI cabang makasar ; 2006.p.
24-31
9. Khan, HA. Clinical significance of HbA1c as marker of circulating lipids
in male and female type 2 diabetic patient. Acta diabetol ; 2007
;(44):193-200
10. PERKENI. Pengelolaan dan Pencegahan Diabetes Melitus Tipe II di
Indonesia 2011. Jakarta : PERKENI; 2011.
11. American Diabetes Assosiation. Standart of medical care in diabetes.
Diabetes care;2004.p. S15-S35.
12. Pujari, S.Subhash. HbA1c as marker of dyslipidemia in type 2 diabetes
mellitus patients.Sch.J.App.Med.Sci, 2013.1(6) : 728-731.
13. Shoback, edited by David G. Gardner, Dolores . Greenspan's basic &
clinical endocrinology(9th ed.). New York: McGraw-Hill Medical.
ISBN 0-07-162243-8;2004.
14. Loei,Glorya Stevani Cicilia, Pandelaki,Karel, Mandang,Veny. Hubungan
kadar HbA1c dengan profil lipid pada pasien diabetes melitus tipe II di
poliklinik endokrin dan metabolic RSUP Prof.DR.D.Kandau Manado.2013
15. Al-alwi, Amur Sulaiman. Serum lipid profile and glycated hemoglobin
status in Omani patients with type 2 diabetes mellitus attending a primary
16. Al- Quran Surah Taha ayat 81.
17. Prabhavathi, Kirthana Kunikullaya, Jaisri Gotoru. Gylcosylated
heamoglobin (HbA1c) a marker of circulating lipid in tupe 2 diabetic
patients. Journal of Clinical and Diagnostic Research. 2014 Feb, Vol -8 (2)
: 20-23.
18. Charitha, B. Arul Senghor, Meera Shivashekar. HbA1c as dual marker in
control glicemic status and diabetic dyslipidemia. International Journal of
Pharmaceutical and Clinical Research 2013 ;5(3) : 111-113.
19. Shoback, edited by David G. Gardner, Dolores (2011).Greenspan's basic
& clinical endocrinology(9th ed.). New York: McGraw-Hill Medical.
pp. Chapter 17. ISBN 0-07-162243-8.
20. Kumar, Vinay; Fausto, Nelson; Abbas, Abul K.; Cotran, Ramzi S. ;
Robbins, Stanley L. Robbins and Cotran Pathologic Basis of Disease(7th
ed.). Philadelphia, Pa.: Saunders. pp. 1194–1195. ISBN 0-7216-0187-1 ;
2004.
21. Anonim A. 2010. Diabetes Mellitus type II. American Diebetes
Assosiation. America.
23. Powers, A.C. Diabetes mellitus. In D.L.Kasper, E.Braunwald, A.S.Fauci,
S.L.Hauser, D.L.Longo, J.L.Jameson: Harrison’s principles of internal
medicine. vol 4. 16th ed. USA: McGraw-Hill Companies, Inc. Hal. 2152.
2005.
24. Guyton, Arthur, Hall, John E. Buku Ajar Fisiologi Kedokteran Edisi 11.
Jakarta: EGC; 2006.
25. American Diabetic Assosiation: standarts of medical care in diabetes 2008
(position statement). Diabetes Care 2008 ;31 (Suppl.1):S12-54
26. Report Of The Expert Committee On The Diagnosis And Classification Of
American Diabetes Mellitus. The Expert Committee On The Diagnosis
And Classification Of The Diabetes Mellitus. Diabetes Care. 2012; 22
(Suppl. 1) : S5–S20.
27. Hardjono. Tes Diabetes Melitus. Dalam Hardjono dkk. Interpretasi Hasil
Diagnostik Tes Laboratorium Diagnostik. Cetakan 3. Lembaga Pendidikan
Universitas Hasanudin. Makasar. 2006. p. 201-06.
28. Rachmawati, A.M., Bahrun, U., Rusli, B., Hardjoeno. Tes Diabetes
Melitus. Dalam Hardjono dkk. Interpretasi Hasil Diagnostik Tes
Laboratorium Diagnostik. Cetakan 3. Lembaga Pendidikan Universitas
Hasanudin. Makasar. 2007. p. 167-82.
29. Soewondo P. Pemantauan Pengendalian Diabetes Mellitus. Dalam
Soegondo S dkk (eds), Penatalaksanaan Diabetes Mellitus Terpadu.
30.Pagana, Desta Kathlen, Pagana,Thymothy. Mosby’s Diagnostic and
Laboratorium Test Reference 11th. Elsevier ; 2012.
31. Plaza, M. N., C. Santana , Y.M. Font, A. M.Mayor, and L. M. Vila.
Assosiasion Hand or Knee Ostheoarthritis With Diabetes Mellitus in a
population of Hispanic Puerto Rico. 2013.
32. Adnan, M. Reumatik non Artikuler. Simposium RNA. Semarang. Oktober
1987:8-14
33. Price, A. Sylvia and L.M. Wilson. Patofisiologi Konsep Dasar Klinik dan
Pneyakit. EGC; 2006.
34. Soegondo, Sidartawan.Diabetes Melitus sebagai faktor resiko utama
penyakit kardiovaskuler.Jakarta: Pendidikan Kedokteran Berkelanjutan
Ikatan Dokter Indonesia:2006.
35. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ
Translating the A1C assay into estimated average glucose
values.".Diabetes Care31(8): 1473–8.
doi:10.2337/dc08-0545. PMC 2742903.PMID 18540046; 2006..
36. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus
[serial online] 2011 [ cited 2014 june 20]; available from :
www.who.int/diabetes/publications/report-hba1c_2011.pdf.
37. Standardisation of the reference method for the measurement of HbA1c to
38.Mayes,PA. Hemoglobin Terglikosilasi Harper’s Biokimia. Edisi 2007.
Jakarta: EGC; 2007.
39. Kee, JL. Pedoman Pemeriksaan Laboratorium dan diagnostic. Jakarta
:EGC; 2003.
40. Soewondo P. Pemantauan Pengendalian Diabetes Mellitus. Dalam
Soegondo S dkk (eds), Penatalaksanaan Diabetes Mellitus Terpadu.
Penerbit FKUI. Jakarta. 2005.
41. Shima K, Chujo K, Yamada M, Komatsu M, Noma Y, Mizuguchi T.
Lower value of glycated haemoglobin relative to glycaemic control in
diabetic patients with end-stage renal disease not on haemodialysis. Ann
Clin Biochem 2012;49:68–74
42. Benuck,I. Gidding SS, Donovan M. Year to year variability pf cholesterol
level in pediatric practice. Arch Pediatric AdolescMed 1995:149:2292-6
43. Sherwood, Lauralee. Fisiologi Manusia dari sel ke system Edisi 6. Jakarta;
EGC;2011.
44. Mogensen, CE and Belfore , F. New Consepts in diabetes and its treatment.
2000.Karger
45. Adam, JMF. Dislipidemia. Dalam : Sudoyono, W.A. Setyohadi, B.Alwi, I.
Buku Ajar Ilmu Penyakit Dalam Jilid III Edisi 4. Jakarta : Pusat Penerbitan
46. Soehartono, Toni. Dislipidemia pada Diabetes Melitus. Dalam:
Djokomoeljanto. Naskah Lengkap ditinjau dari Berbagai Aspek Penyakit
Dalam. Semarang: Badan Penerbit Universitas Diponegoro;2007.
47.Jawaharlal W.B. Senaratne and Green FR. Pathobiology of atherosclerosis. In
Peter J. Morris,William C. Wood Oxford eds. Textbook of Surgery, 2nd edition.
US: Oxford press; 2000: Vol. 3
48. Frank MS, McPerson R, Brian W, Effect of post menopausal estrogen
replacement on plasma Lp(a) Lipoprotein Concentrations, Arch Intern Med,
1994, 154-,1106-10.
49. Ricart, W. & Real, J.M. F.. No Decrase in Free IGF-I with Increasing
Insulin in Obesity-Related Insulin Resistance. Obesity Research, 9,
631-636, 2001.
50. Lemeshow,S; DW Hosmer Jr. Adequacy of Sample Size in Health Studies.
WHO. John Wiley and Sons Ltd. England. 1993.
51. Sastroasmoro, Sudigdo. Pengukuran dalam Penelitian. In: Sastroasmoro S
dan Ismael S. Dasar dasar Metodologi Penelitian Klinis Edisi Ketiga.
Jakarta : Seagung Seto; 2007.
52. Bahri,A. Dislipidemia Sebagai Faktor Resiko Penyakit Jantung Koroner.
E-USU Respirator. Fakultas Kedokteran Univeristas Sumatra Utara;2004.
53. Tumbeleka AR, Riono P. Pemilihan Uji Hipotesis In: In: Sastroasmoro S
54. Data Rekam Medis Rumah Sakit Umum Daerah Dr. Adhiatma Semarang
Poli Penyakit Dalam Periode 1 Januari 2013–31 Desember 2013.
55. Effendi, Rustam. Gambaran distribusi penderita diabetes melitus rawat jalan
di badan RSUD Manna Bengkulu Selatan 1999-2001; Universitas Sumatra
Utara. 2012.
56. Josten, S, Mutmainnah, Hardjoeno. Profil lipid penderita diabetes melitus
tipe 2.Indonesian Journal of clinical pathology dan medical laboratory, Vol
13, No.1 Nov 2006 ;20-22.
57. Ramona, gligor, dkk. Relationship between glycosylated hemoglobin and
lipid metabolism in patients with type 2 diabetes. Journal studia
universitatis “Vashile Gordis” Vol 21, Issue 2, 2011, pp. 313-318.
58. Shivanand, K.G. Lipid profile and its complication in diabetes melitus.
IJBAR. 2012. Diperoleh ari :http://ijbar.ssjournal.com. Diakses 1 november
2014.
59. Adm. Kadar HbA1c mencerminkan kadar profil lipid. Sept. 2011. Diperoleh
